Nxera Pharma Co., Ltd. (SOLTF)
OTCMKTS
· Delayed Price · Currency is USD
5.91
-0.49 (-7.66%)
May 2, 2025, 4:00 PM EDT
Nxera Pharma Employees
Nxera Pharma had 374 employees as of December 31, 2024. The number of employees increased by 24 or 6.86% compared to the previous year.
Employees
374
Change (1Y)
24
Growth (1Y)
6.86%
Revenue / Employee
$551,158
Profits / Employee
-$41,371
Market Cap
581.60M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Endo Inc. | 3,116 |
Tian'an Technology Group | 8 |
Glass House Brands | 374 |
Elite Pharmaceuticals | 64 |
Northwest Biotherapeutics | 25 |
CytoDyn | 9 |
American Oncology Network | 1,914 |
Silence Therapeutics | 116 |
Nxera Pharma News
- 3 days ago - Nxera Pharma Operational Highlights and Consolidated Results for the First Quarter 2025 - GlobeNewsWire
- 4 days ago - Nxera Pharma's Partner Neurocrine Biosciences Initiates Phase 3 Registrational Program of NBI-1117568 as a Potential Treatment for Adults with Schizophrenia - GlobeNewsWire
- 4 days ago - Nxera Pharma Appoints Top-Ranked Biopharma Investment Analyst Shinya Tsuzuki as Head of Investor Relations - GlobeNewsWire
- 4 weeks ago - Nxera Pharma Announces Appointments to its Executive Leadership Team - GlobeNewsWire
- 5 weeks ago - Nxera Pharma's Partner Tempero Bio Initiates Phase 2 Trial with TMP-301 for Alcohol Use Disorder - GlobeNewsWire
- 2 months ago - Nxera Pharma Enters Agreement with Holling to Commercialize Daridorexant in Taiwan - GlobeNewsWire
- 2 months ago - Nxera Pharma Proposes Changes to its Board of Directors - GlobeNewsWire
- 2 months ago - Nxera Pharma Operational Highlights and Consolidated Results for the Fourth Quarter and Full Year 2024 - GlobeNewsWire